Wealthstar Advisors invested $1.12 million in Globus Medical, a medical device company, acquiring 15,252 shares.

Wealthstar Advisors invested $1.12 million in Globus Medical, a company that makes healthcare solutions for musculoskeletal disorders, by acquiring 15,252 shares. Despite a slight miss in earnings and revenue, analysts predict Globus Medical will post 3.44 EPS for the year. The stock has a 'Moderate Buy' rating and a target price of $94.00. Meanwhile, Lisanti Capital slightly reduced its holdings in the company.